(E75) Disorders of sphingolipid metabolism and other lipid storage disorders

More details coming soon

Icon
59 638 in individuals diagnosis disorders of sphingolipid metabolism and other lipid storage disorders confirmed
Icon
10 673 deaths with diagnosis disorders of sphingolipid metabolism and other lipid storage disorders
Icon
18% mortality rate associated with the disease disorders of sphingolipid metabolism and other lipid storage disorders

Diagnosis disorders of sphingolipid metabolism and other lipid storage disorders is diagnosed Men are 26.00% more likely than Women

37 571

Men receive the diagnosis disorders of sphingolipid metabolism and other lipid storage disorders

5 833 (15.5 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
22 067

Women receive the diagnosis disorders of sphingolipid metabolism and other lipid storage disorders

4 840 (21.9 %)

Died from this diagnosis.

Risk Group for the Disease disorders of sphingolipid metabolism and other lipid storage disorders - Men and Women aged 5-9

Icon
In Men diagnosis is most often set at age 0-79
Icon
Less common in men the disease occurs at Age 80-95+Less common in women the disease occurs at Age 70-95+
Icon
In Women diagnosis is most often set at age 0-69

Disease Features disorders of sphingolipid metabolism and other lipid storage disorders

Icon
Absence or low individual and public risk
Icon

Disorders of sphingolipid metabolism and other lipid storage disorders - what does this mean

Disorders of sphingolipid metabolism and other lipid storage disorders occur when the body is unable to properly break down and store certain types of lipids, such as sphingolipids. this can lead to the accumulation of these lipids in the body, which can cause a variety of health problems, including neurological and muscular disorders, skin disorders, and even death.

What happens during the disease - disorders of sphingolipid metabolism and other lipid storage disorders

Disorders of sphingolipid metabolism and other lipid storage disorders are caused by mutations in genes that are responsible for the production, transport, and breakdown of sphingolipids and other lipids. these mutations lead to an accumulation of these lipids in the body, which can cause a variety of health problems, including neurological and cardiovascular issues.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Blood tests to measure levels of sphingolipids
  • Urine tests to measure levels of sphingolipids
  • Liver function tests
  • Imaging tests such as MRI or CT scans
  • Genetic testing to identify mutations in genes that are associated with sphingolipid metabolism disorders
  • Biopsies of skin or muscle tissue to examine the accumulation of sphingolipids

Treatment and Medical Assistance

Main Goal of Treatment: To reduce symptoms and improve quality of life
  • Regular monitoring of lipid levels in the blood
  • Dietary changes to reduce fat and cholesterol intake
  • Medication to lower cholesterol and triglyceride levels
  • Exercise to improve metabolic health
  • Vitamin and mineral supplements to correct any deficiencies
  • Regular monitoring of liver enzymes
  • Regular monitoring of liver and kidney function
  • Regular monitoring of neurological function
  • Regular monitoring of vision and hearing
  • Regular monitoring of growth and development in children
  • Regular monitoring of skin and hair health
  • Regular monitoring of heart health
  • Regular monitoring of blood sugar levels
Icon
30 Days of Hospitalization Required
Icon
203 Hours Required for Outpatient Treatment

Disorders of sphingolipid metabolism and other lipid storage disorders - Prevention

The best way to prevent disorders of sphingolipid metabolism and other lipid storage disorders is to maintain a healthy lifestyle, including a balanced diet and regular physical activity. additionally, it is important to monitor cholesterol levels, as high levels may be an indication of an underlying disorder. lastly, it is important to be aware of family history and to speak to a doctor if there is any concern about potential genetic predisposition.

Specified forms of the disease

(E75.0) GM 2 gangliosidosis
(E75.1) Other gangliosidosis
(E75.2) Other sphingolipidosis
(E75.3) Sphingolipidosis, unspecified
(E75.4) Neuronal ceroid lipofuscinosis
(E75.5) Other lipid storage disorders
(E75.6) Lipid storage disorder, unspecified